Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
China Journal of Chinese Materia Medica ; (24): 745-752, 2022.
Article in Chinese | WPRIM | ID: wpr-927958

ABSTRACT

The present study analyzed the correlations between curcumin(Cur), nuclear factor E2 related factor 2(NRF2)-dimethylarginine dimethylaminohydrolase(DDAH)-asymmetric dimethylarginine(ADMA)-nitric oxide(NO) pathway, and endothelial-mesenchymal transition(EndMT) based on SD rats with cardiac fibrosis, and explored the effect and mechanism of Cur in resisting cardiac fibrosis to provide an in-depth theoretical basis for its clinical application in the treatment of heart failure. The cardiac fibrosis model was induced by subcutaneous injection of isoprenaline(Iso) in rats. Thirty-two rats were randomly divided into a control group, a model group, a low-dose Cur group(100 mg·kg~(-1)·d~(-1)), and a high-dose Cur group(200 mg·kg~(-1)·d~(-1)), with eight in each group. After 21 days of treatment, cardiac function was detected by echocardiography, degree of cardiac fibrosis by Masson staining, expression of CD31 and α-SMA by pathological staining, expression of VE-cadherin, vimentin, NRF2, and DDAH by Western blot, and ADMA level by HPLC. Compared with the model group, the Cur groups showed alleviated cardiac fibrosis, accompanied by increased CD31 and VE-cadherin expression and decreased α-SMA and vimentin expression, indicating relieved EndMT. Additionally, DDAH and NRF2 levels were elevated and ADMA and NO expression declined. Cur improves cardiac fibrosis by inhibiting EndMT presumedly through the NRF2-DDAH-ADMA-NO pathway.


Subject(s)
Animals , Rats , Amidohydrolases/metabolism , Curcumin , Fibrosis , NF-E2-Related Factor 2/genetics , Nitric Oxide/metabolism , Rats, Sprague-Dawley
2.
China Journal of Chinese Materia Medica ; (24): 1460-1466, 2021.
Article in Chinese | WPRIM | ID: wpr-879051

ABSTRACT

This project aimed to explore the protective effect of ginsenoside Rg_1 on hypoxia/reoxygenation(H/R)-induced H9 c2 cardiomyocyte injury and its underlying signaling pathway. The H/R model of H9 c2 cardiomyocytes was established and then the cells were divided into different treatment groups. CCK-8(cell counting kit-8) was used to detect the activity of cardiomyocytes; Brdu assay was used to detect the proliferation of H9 c2 cells; the caspase-3 activity was tested, and then the protein expression was assessed by Western blot. Flow cytometry was used to evaluate the apoptosis level of cardiomyocytes. Ginsenoside Rg_1 inhibited H/R-induced cardiomyocyte apoptosis and caspase-3 activity, promoted nuclear transcription of nuclear factor erythroid-2 related factor 2(Nrf2), and enhanced the expression of the downstream heme oxygenase-1(HO-1). Ginsenoside Rg_1 could increase Nrf2 nuclear transcription and HO-1 expression with the increase of concentration(10, 20, 40, 60 μmol·L~(-1)). However, the protective effect of ginsenoside Rg_1 on cardiomyocytes was significantly weakened after the transfection of Nrf2-siRNA. Ginsenoside Rg_1 could protect cardiomyocytes by activating the Nrf2/HO-1 pathway.


Subject(s)
Humans , Apoptosis , Ginsenosides/pharmacology , Heme Oxygenase-1/genetics , Hypoxia , Myocytes, Cardiac , NF-E2-Related Factor 2/genetics
3.
Chinese Journal of Natural Medicines (English Ed.) ; (6): 721-731, 2021.
Article in English | WPRIM | ID: wpr-922755

ABSTRACT

Chitooligosaccharide-zinc (COS·Zn) is a powerful anti-oxidant and anti-aging scavenger, whose anti-oxidative ability immensely exceeds vitamin C. Therefore, this study was aimed to investigate the protective effects of COS·Zn against premature ovarian failure (POF) and potential mechanisms. Female KM adult mice were divided into the following groups: a treatment group (150 mg·kg


Subject(s)
Animals , Female , Humans , Mice , Chitosan , NF-E2-Related Factor 2/genetics , Nuclear Proteins , Oligosaccharides , Primary Ovarian Insufficiency/drug therapy , Signal Transduction , Zinc
4.
Rev. bras. cancerol ; 66(1): 1-11, 20200129.
Article in Portuguese | LILACS | ID: biblio-1095406

ABSTRACT

Introdução: O fator nuclear eritroide 2 relacionado ao fator 2 (Nrf2) desempenha papel fundamental na expressão de genes mediados por elemento de resposta antioxidante (ERA); sendo assim, é uma via importante para proteger as células de substâncias carcinogênicas. Objetivo: Realizar uma revisão integrativa da literatura acerca da ação quimiopreventiva dos fitoquímicos por meio da regulação do fator de transcrição Nrf2. Método: O levantamento de artigos para a revisão integrativa da literatura sobre essa temática foi realizado nos periódicos indexados nas bases de dados: Google Acadêmico, PubMed, SciELO, ScienceDirect e SpringerLink, utilizando-se os descritores advindos do MeSH: fitoquímicos, radicais livres, estresse oxidativo, carcinogênese, quimioprevenção e Nrf2. Os critérios de seleção foram artigos publicados de 2000 a 2019, relacionados, ou que investiguem diretamente a atuação de fitoquímicos no fator de transcrição Nrf2, e a prevenção do desenvolvimento de câncer. Resultados: Foram selecionados 58 artigos que estavam relacionados com o objetivo da revisão. Os estudos revisados apontaram que fitoquímicos, tais como resveratrol, curcumina, isotiocianato, luteolina, entre outros, atuam na ativação da via Nrf2, utilizando diferentes mecanismos, sendo eles dependentes ou independentes da proteína repressora Kelch-Like Epichlorohydrin-Associated Protein 1. Conclusão: Diante disso, conclui-se que a modulação do fator de transcrição Nrf2 é um mecanismo que se configura como um importante mediador no que concerne compostos nocivos ao organismo humano, e que a atuação dos fitoquímicos nessa via contribui para a redução do risco de câncer. No entanto, ainda não são completamente elucidados todos os mecanismos utilizados pelos fitoquímicos, sendo necessários ulteriores estudos na área


Introduction: The nuclear factor erythroid 2-related factor 2 (NRF2) plays a fundamental role in the expression of genes mediated by antioxidant response element (ARE), thus it is an important pathway to protect the cells from carcinogenic substances. Objective: To perform an integrative literature review on the quimiopreventive action of phytochemicals through regulation of the transcription factor Nrf2. Method: Search of papers for the integrative literature review about this theme conducted in journals indexed in the databases: Academic Google, PubMed, SciELO, ScienceDirect and Springer Link, using the MeSH descriptors: phytochemicals, free radicals, oxidative stress, carcinogenesis, chemoprevention and Nrf2. The selection criteria were articles published from 2000 to 2019, related to or that directly investigate the role of phytochemicals in the transcription factor Nrf2, and the prevention of cancer development. Results: 58 articles were selected, all related to the objective of the review. The reviewed studies showed that phytochemicals, such as resveratrol, curcumin, isothiocyanate, luteolin, among others, act on the activation of the Nrf2 pathway, using different mechanisms, which are dependent or independent of the repressor protein Kelch-Like Epichlorohydrin-Associated Protein 1. Conclusion: Therefore, the conclusion is that the modulation of the transcription factor Nrf2 is a mechanism that configures itself as an important mediator for harmful compounds to the human organism, and that the action of phytochemicals, in this pathway, contributes to the reduction of cancer risk. However, all the mechanisms used by phytochemicals, are not completely elucidated, and further studies are needed in the area


Introducción: El factor nuclear eritroide 2 relacionado con el factor 2 (Nrf2) desenvuelve un papel fundamental en la expresión de los genes mediados por él elemento de respuesta antioxidante (ERA), por lo tanto, es una vía importante para proteger las células de las sustancias carcinógenas. Objetivo: Realizar una revisión integradora de la literatura sobre la acción quimiopreventiva de los fitoquímicos mediante la regulación del factor de transcripción Nrf2. Método: El levantamiento de artículos para la revisión integral de la literatura sobre este tema se realizó en revistas indexadas en las bases de datos: Google Académico, PubMed, Scielo, ScienceDirect y SpringerLink, usando los descriptores MeSH: fitoquímicos, radicales libres, estrés oxidativo, carcinogénesis, quimioprevención y Nrf2. Los criterios de selección fueron artículos publicados entre 2000 y 2019, relacionados o que investigan directamente el papel de los fitoquímicos en el factor de transcripción Nrf2 y la prevención del desarrollo del câncer. Resultados: 58 artículos relacionados con el objetivo de la revisión fueron seleccionados. Los estudios revisados mostraron que los fitoquímicos, como el resveratrol, la curcumina, el isotiocito, la luteolina, entre otros, actúan sobre la activación de la vía Nrf2, utilizando diferentes mecanismos, que son dependientes o independientes de la proteína represora Kelch-Like Epichlorohydrin-Associated Protein 1. Conclusión: Por lo tanto, se concluí que la modulación del factor de transcripción Nrf2 es un mecanismo que se configura como un importante mediador en relación con los compuestos nocivos para el cuerpo humano, y que la acción de los fitoquímicos en esta vía contribuye a reducir el riesgo de cáncer. Sin embargo, todos los mecanismos utilizados por los fitoquímicos aún no se han dilucidado por completo, por lo que se necesitan más estudios en esta área


Subject(s)
Humans , Animals , Male , Female , NF-E2-Related Factor 2/metabolism , Carcinogenesis/drug effects , Phytochemicals/pharmacology , Neoplasms/prevention & control , Oxidative Stress , Diet , NF-E2-Related Factor 2/genetics , NF-E2-Related Factor 2/therapeutic use , Antioxidant Response Elements , Free Radicals , Antioxidants
5.
Biomédica (Bogotá) ; 37(3): 378-389, jul.-set. 2017. tab, graf
Article in Spanish | LILACS | ID: biblio-888478

ABSTRACT

Resumen Introducción. Dada la resistencia de Plasmodium a los medicamentos antipalúdicos, es necesario encontrar nuevas alternativas terapéuticas para su tratamiento y control. Con base en el saber indígena colombiano, se recopilaron extractos de plantas del Vaupés medio con potencial efecto antipalúdico. Objetivo. Evaluar el efecto mutagénico y genotóxico, y la expresión de los genes Rad51C, Xiap, P53 yNrf2, inducidos por cuatro extractos etanólicos con actividad anti-Plasmodium(R001, T002, T015 y T028). Materiales y métodos. Se evaluó el potencial mutagénico de cuatro extractos etanólicos con efecto antiplasmódico utilizando el test de Ames y el efecto genotóxico, con un ensayo del cometa; asimismo, se analizó la expresión de los genes Rad51C, Xiap, P53 y Nrf2 en células HepG2. Resultados. Los extractos no fueron mutágenos en la cepa TA98 de Salmonella typhimurium en presencia y ausencia de actividad metabólica de la fracción S9. En la cepa TA100, los extractos R001, T015 y T028 se comportaron como mutágenos débiles en presencia de S9, con índices mutagénicos de 1,58; 1,38; 1,53 y 1,61, respectivamente; T015 tuvo el mismo comportamiento en ausencia de S9, con un índice mutagénico de 1,36. En el ensayo del cometa, todos los extractos provocaron daño de categorías 1 o 2, con colas de cometas entre 36,7 y 51,48 µm de longitud; sin embargo, el índice dedaño genético sugirió que los tratamientos afectaron la mayoría de las células. En los genes en estudio, los extractos R001 y T028 indujeron una sobreexpresiónde 1,84 a 3,99 frente a las células sin tratar de los genes Xiap y P53. Conclusiones. Los resultados evidenciaron que el extracto T002 fue el más seguro, ya que presentó actividad anti-Plasmodium, no fue citotóxico en las células HepG2, no fue mutágeno, causó daño de categoría 1 en el ADN y no modificó la expresión de los genes evaluados.


Abstracts Introduction: Due to Plasmodium resistance to antimalarial drugs, it is important to find new therapeutic alternatives for malaria treatment and control. Based on the knowledge of Colombian indigenous communities, we collected extracts of plants with potential antimalarial effects from the middle Vaupés region. Objective: To evaluate the mutagenic and genotoxic effects, as well as the gene expression of Rad51C, Xiap, P53 and Nrf2 induced by four ethanolic extracts with antimalarial activity (R001, T002, T015 and T028). Materials and methods: We evaluated four ethanolic extracts with antimalarial activity using the Ames test to assess mutagenicity, and the comet assay on HepG2 cells to determine the genotoxicicity. We also evaluated the expression of Rad51C, Xiap, P53 and Nrf2 from HepG2 cells stimulated with the four extracts. Results: None of the four extracts was mutagenic in Salmonella typhimurium TA98 strain in the presence and absence of S9 metabolic activity. Extracts R001, T015 and T028 were weakly mutagenic on the TA100 strain in the presence of S9, with mutagenic indexes (MI) of 1.58, 1.53 and 1.61, respectively. The T015 strain showed the same behavior without S9 with an MI of 1.36. The results of the comet assay showed that the four extracts produced category 1 or 2 damage, with comets between 36.7 and 51.48 µm in length. However, the genetic damage index suggested that most of the cells were affected by the treatments. Regarding gene expression, extracts R001 and T028 induced an overexpression of genes Xiap and P53 with an 1.84 to 3.99 fold-change compared with untreated cells. Conclusions: These results revealed that the T002 extract was the safest as it had antimalarial activity and was not cytotoxic on HepG2 cells. Moreover, it was not mutagenic and it only produced category 1 damage on the DNA. Also, the extract did not induce a change in the expression of the tested genes.


Subject(s)
Humans , Plants, Medicinal/chemistry , Plant Extracts/pharmacology , Gene Expression Regulation/drug effects , Tumor Suppressor Protein p53/biosynthesis , DNA-Binding Proteins/biosynthesis , X-Linked Inhibitor of Apoptosis Protein/biosynthesis , NF-E2-Related Factor 2/biosynthesis , Antimalarials/pharmacology , Plasmodium falciparum/drug effects , Salmonella typhimurium/drug effects , Salmonella typhimurium/genetics , Solvents , Plant Extracts/isolation & purification , Tumor Suppressor Protein p53/genetics , Colombia , Comet Assay , Ethanol , DNA-Binding Proteins/genetics , Drug Evaluation, Preclinical , X-Linked Inhibitor of Apoptosis Protein/genetics , NF-E2-Related Factor 2/genetics , Hep G2 Cells , Activation, Metabolic , Genes, Bacterial/drug effects , Mutagenicity Tests , Antimalarials/isolation & purification
6.
Experimental & Molecular Medicine ; : e142-2015.
Article in English | WPRIM | ID: wpr-42471

ABSTRACT

Bucillamine is used for the treatment of rheumatoid arthritis. This study investigated the protective effects of bucillamine against cisplatin-induced damage in auditory cells, the organ of Corti from postnatal rats (P2) and adult Balb/C mice. Cisplatin increases the catalytic activity of caspase-3 and caspase-8 proteases and the production of free radicals, which were significantly suppressed by pretreatment with bucillamine. Bucillamine induces the intranuclear translocation of Nrf2 and thereby increases the expression of gamma-glutamylcysteine synthetase (gamma-GCS) and glutathione synthetase (GSS), which further induces intracellular antioxidant glutathione (GSH), heme oxygenase 1 (HO-1) and superoxide dismutase 2 (SOD2). However, knockdown studies of HO-1 and SOD2 suggest that the protective effect of bucillamine against cisplatin is independent of the enzymatic activity of HO-1 and SOD. Furthermore, pretreatment with bucillamine protects sensory hair cells on organ of Corti explants from cisplatin-induced cytotoxicity concomitantly with inhibition of caspase-3 activation. The auditory-brainstem-evoked response of cisplatin-injected mice shows marked increases in hearing threshold shifts, which was markedly suppressed by pretreatment with bucillamine in vivo. Taken together, bucillamine protects sensory hair cells from cisplatin through a scavenging effect on itself, as well as the induction of intracellular GSH.


Subject(s)
Animals , Male , Mice , Rats , Antioxidants/metabolism , Apoptosis/drug effects , Caspase 3/metabolism , Caspase 8/metabolism , Cell Line , Cisplatin/toxicity , Cysteine/analogs & derivatives , Gene Expression Regulation/drug effects , Gene Knockdown Techniques , Glutathione/metabolism , Heme Oxygenase-1/genetics , Intracellular Space/metabolism , Metabolic Detoxication, Phase II/genetics , NF-E2-Related Factor 2/genetics , Nitric Oxide/biosynthesis , Organ of Corti/drug effects , RNA Interference , Reactive Oxygen Species/metabolism , Superoxide Dismutase/genetics
7.
Experimental & Molecular Medicine ; : 787-797, 2010.
Article in English | WPRIM | ID: wpr-122637

ABSTRACT

Cholangiocarcinoma (CC) is a chemoresistant intrahepatic bile duct carcinoma with a poor prognosis. The aims of this study were to identify molecular pathways that enhance sesquiterpene lactone parthenolide (PTL)-induced anticancer effects on CC cells. The effects of PTL on apoptosis and hemoxygenase-1 (HO-1) induction were examined in CC cell lines. The enhancement of PTL-mediated apoptosis by modulation of HO-1 expression and the mechanisms involved were also examined in an in vitro cell system. Low PTL concentrations (5 to 10 micrometer) led to Nrf2-dependent HO-1 induction, which attenuated the apoptogenic effect of PTL in Choi-CK and SCK cells. PTL-mediated apoptosis was enhanced by the protein kinase C-alpha inhibitor Ro317549 (Ro) through inhibition of expression and nuclear translocation of Nrf2, resulting in blockage of HO-1 expression. Finally, HO-1 silencing resulted in enhancement of apoptotic cell death in CC cells. The combination of PTL and Ro efficiently improved tumor growth inhibition compared to treatment with either agent alone in an in vivo subcutaneous tumor model. In conclusion, the modulation of HO-1 expression substantially improved the anticancer effect of PTL. The combination of PTL and Ro could prove to be a valuable chemotherapeutic strategy for CC.


Subject(s)
Humans , Active Transport, Cell Nucleus/drug effects , Antineoplastic Agents/chemistry , Apoptosis/drug effects , Cell Line, Tumor , Cell Nucleus/metabolism , Cholangiocarcinoma/drug therapy , Drug Resistance, Neoplasm/drug effects , Enzyme Activation , Enzyme Inhibitors/pharmacology , Heme Oxygenase-1/genetics , Lactones/chemistry , NF-E2-Related Factor 2/genetics , Protein Kinase C-alpha/antagonists & inhibitors , RNA, Small Interfering/genetics , Sesquiterpenes/chemistry , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL